BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17868485)

  • 1. Elevated HCG outside of pregnancy--diagnostic considerations and laboratory evaluation.
    Olsen TG; Barnes AA; King JA
    Obstet Gynecol Surv; 2007 Oct; 62(10):669-74; quiz 691. PubMed ID: 17868485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The follow-up of trophoblastic disease by using an hCG-CTP enzyme immunoassay].
    Matsuura Y; Kashimura M; Shinohara M; Baba S; Kondo M; Kashimura Y
    Gan No Rinsho; 1990 Dec; 36(15):2559-62. PubMed ID: 2176247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
    Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
    Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum beta-human chorionic gonadotropin in nonpregnant conditions.
    Demirtas E; Krishnamurthy S; Tulandi T
    Obstet Gynecol Surv; 2007 Oct; 62(10):675-9; quiz 691. PubMed ID: 17868483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of human chorionic gonadotropin and alpha-subunit measurements.
    Hussa RO
    Obstet Gynecol; 1982 Jul; 60(1):1-12. PubMed ID: 6283446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
    Kitajima T; Mochizuki M; Nishimura R
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of HCG and hCG beta determinations.
    Mann K; Saller B; Hoermann R
    Scand J Clin Lab Invest Suppl; 1993; 216():97-104. PubMed ID: 7690985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HCG and SP-1 as markers in trophoblast tumors. The HCG/SP-1 ratio].
    Than GN; Tatra G; Csaba IF; Szabo DG; Bohn H
    Gynakol Rundsch; 1988; 28(3):157-65. PubMed ID: 2844633
    [No Abstract]   [Full Text] [Related]  

  • 12. Human chorionic gonadotropin assays and their uses.
    Tyrey L
    Obstet Gynecol Clin North Am; 1988 Sep; 15(3):457-75. PubMed ID: 2852329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin.
    Khanlian SA; Cole LA
    J Reprod Med; 2006 Oct; 51(10):812-8. PubMed ID: 17086809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non trophoblastic source of human chorionic gonadotropin - problem in diagnostic accuracy.
    Dabrowski F; Grzechocinska B; Cyganek A; Wielgos M
    Neuro Endocrinol Lett; 2015; 36(4):316-9. PubMed ID: 26454486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human chorionic gonadotropin in cancer.
    Stenman UH; Alfthan H; Hotakainen K
    Clin Biochem; 2004 Jul; 37(7):549-61. PubMed ID: 15234236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestation trophoblastic diseases: management of cases with persistent low human chorionic gonadotropin results.
    Cole LA; Kohorn E; Smith HO
    Obstet Gynecol Clin North Am; 2005 Dec; 32(4):615-26. PubMed ID: 16310675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
    Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
    Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA; Sutton JM
    J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
    Cole LA; Kohorn EI; Kim GS
    J Reprod Med; 1994 Mar; 39(3):193-200. PubMed ID: 8035374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
    Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.